ARTICLE | Clinical News
Lemuteporfin: Phase I/II halted
August 4, 2008 7:00 AM UTC
QLT said it plans to halt development of lemuteporfin to treat acne after an interim review of data from a Phase I/II trial showed the product did not meet an internal therapeutic threshold. In 2006, ...